IF a sequence-context-guided epigenetic repair strategy — combining computational identification of R882H-preferential CpG targets (using the known +3-position flanking sequence preference profile) with catalytically inactive Cas9 fused to TET1 catalytic domain (dCas9-TET1) delivered via lipid nanoparticle to hematopoietic stem and progenitor cells (HSPCs) in aged mice (18–24 months, mixed sex, C57BL/6J background carrying hDNMT3A R882H in the hematopoietic compartment) — is administered as a multiplexed sgRNA panel targeting the top 20–50 aberrantly hypermethylated CpG loci predicted by R882H sequence-context modeling,

THEN measurable reversal of the accumulated R882H-driven hypermethylation signature (≥40% reduction in methylation beta values at targeted CpGs by bisulfite sequencing), partial restoration of the epigenetic age clock toward younger reference animals, and attenuation of motor and neurological pathology (CatWalk gait score normalization) will be observed within 16 weeks of treatment,

BECAUSE the following causal chain is supported by the evidence:

1. The R882H mutation does not cause uniform loss of function but instead generates a predictable, sequence-context-dependent methylation error map: hypermethylation at CpGs flanked by R882H-preferred sequences (up to 5-fold overactivity) and hypomethylation at R882H-disfavored contexts (up to 7-fold underactivity), with the structural basis residing at the +3 DNA backbone contact position within the tetramer interface — this makes the damage pattern computationally decodable and spatially specific (R882H sequence preference model)[https://pmc.ncbi.nlm.nih.gov/articles/PMC5887309/].

2. Because R882H maintains near-normal DNA binding affinity (KD ~209 nM vs. 183 nM wildtype) and preserves the regulatory domain interface (residues 612–912), the aberrant methylation is not caused by loss of chromatin access or wholesale tetramer collapse — it is caused by mis-recognition at the +3 position, meaning the accumulated hypermethylation at specific loci is a discrete, addressable substrate for active demethylation (structural preservation of binding)[https://pmc.ncbi.nlm.nih.gov/articles/PMC5887309/].

3. Hematopoietic cells carrying R882H, when expanded as CHIP clones, produce monocyte-derived microglia that colonize the brain and cause basal ganglia motor pathology in aged mice — establishing that the downstream damage from R882H epigenetic errors is real, progressive, and neurologically consequential, and that repair of the epigenetic error within the hematopoietic compartment is a logical upstream intervention point (monocyte-derived microglia with R882H cause motor pathology)[https://doi.org/10.1101/2023.11.16.567402].

4. Targeted epigenetic editing at individual age-associated CpGs does not produce isolated corrections but generates genome-wide shifts in the epigenetic aging landscape, including bystander modifications not attributable to CRISPR off-target sites — demonstrating th...

SENS category: OncoSENS

Key references: • doi.org/10.1101/2023.11.16.567402]. • doi.org/10.1101/2024.06.04.597161]. • doi.org/10.1038/s41422-020-0359-9]. • doi.org/10.1186/s12864-015-1381-z]. • doi.org/10.1101/2025.04.15.25325668].